Jennifer A. Fox
CIK: 0001841557
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 3, 2026APGE
Apogee Therapeutics, Inc.
Disposition(D)Direct34.8K shares- - Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
Award(A)DirectStock Option (Right to Buy)
125K shares- - Jun 9, 2026APGE
Apogee Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
7.7K shares- - May 28, 2026PROK
PROKIDNEY CORP.
Award(A)DirectDirector stock option (right to buy)
135K shares- - Feb 5, 2026ZBIO
Zenas BioPharma, Inc.
Award(A)Direct1.6K shares at avg. $13.35$21K - Jun 17, 2025APGE
Apogee Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
14.5K shares- - Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
Award(A)DirectStock Option (Right to Buy)
150K shares- - May 29, 2025PROK
PROKIDNEY CORP.
Award(A)DirectDirector stock option (right to buy)
125.9K shares- - Dec 16, 2024ZBIO
Zenas BioPharma, Inc.
Award(A)DirectStock Option (Right to Buy)
8.1K shares- - Sep 12, 2024ZBIO
Zenas BioPharma, Inc.
Award(A)DirectStock Option (Right to Buy)
155K shares- - Sep 3, 2024PROK
PROKIDNEY CORP.
Award(A)DirectDirector stock option (right to buy)
9.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition(D) | 34,824 | - | $0 | Direct |
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award(A) Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Jun 9, 2026 | APGE Apogee Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 7,657 | - | - | Direct |
| May 28, 2026 |  PROK PROKIDNEY CORP. | Award(A) Director stock option (right to buy) | 135,000 | - | - | Direct |
| Feb 5, 2026 | ZBIO Zenas BioPharma, Inc. | Award(A) | 1,592 | $13.35 | $21,253 | Direct |
| Jun 17, 2025 | APGE Apogee Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 14,461 | - | - | Direct |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | Award(A) Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| May 29, 2025 | PROK PROKIDNEY CORP. | Award(A) Director stock option (right to buy) | 125,862 | - | - | Direct |
| Dec 16, 2024 | ZBIO Zenas BioPharma, Inc. | Award(A) Stock Option (Right to Buy) | 8,125 | - | - | Direct |
| Sep 12, 2024 | ZBIO Zenas BioPharma, Inc. | Award(A) Stock Option (Right to Buy) | 155,000 | - | - | Direct |
| Sep 3, 2024 | PROK PROKIDNEY CORP. | Award(A) Director stock option (right to buy) | 9,535 | - | - | Direct |
1-11 of 11 transactions
About Fox Jennifer A.
Fox Jennifer A. (SEC CIK 0001841557) files insider reports with the SEC as Director of Apogee Therapeutics, Inc. (APGE), Officer of Zenas BioPharma, Inc. (ZBIO) and Director of PROKIDNEY CORP. (PROK).
Signal8 holds 11 ownership filings by Fox Jennifer A. (1 Form 3, 10 Form 4), filed between Sep 4, 2024 and Sep 3, 2026. Those filings report 11 transactions, from Sep 3, 2024 to Sep 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fox Jennifer A.'s filings is in SAN FRANCISCO, CA.
Recent filings by Fox Jennifer A.
- Sep 3, 2026: Disposition to issuer transaction of APGE shares (Form 4, code D).
- Jun 15, 2026: Grant or award of ZBIO derivative securities (Form 4, code A).
- Jun 9, 2026: Grant or award of APGE derivative securities (Form 4, code A).
- May 28, 2026: Grant or award of PROK derivative securities (Form 4, code A).
- Feb 5, 2026: Grant or award of ZBIO shares (Form 4, code A).
Other insiders filing for Apogee Therapeutics, Inc. (APGE)
- Fairmount Funds Management LLC, Director
- McKenna Mark C., Director
- JONES WILLIAM A JR, Director
- Dambkowski Carl, Chief Medical Officer
- Henderson Jane, Chief Financial Officer
- Bollinger Lisa, Director